 | • レポートコード：GIR-105X09821 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、イキサゾミブのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。イキサゾミブの種類別市場規模（2.3mgカプセル、3mgカプセル、4mgカプセル）、用途別市場規模（病院、クリニック、ドラッグセンター、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・イキサゾミブの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Takeda ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：2.3mgカプセル、3mgカプセル、4mgカプセル ・用途別分析2016年-2026年：病院、クリニック、ドラッグセンター、その他 ・イキサゾミブの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・イキサゾミブのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・イキサゾミブのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・イキサゾミブの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・イキサゾミブの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Ixazomib market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Ixazomib size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Ixazomib market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Ixazomib market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
2.3mg Capsules
3mg Capsules
4mg Capsules
Market segment by Application can be divided into
Hospital
Clinic
Drug Center
Other
The key market players for global Ixazomib market are listed below:
Takeda
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Ixazomib Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Ixazomib Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 2.3mg Capsules
1.2.3 3mg Capsules
1.2.4 4mg Capsules
1.3 Market Analysis by Application
1.3.1 Overview: Global Ixazomib Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Drug Center
1.3.5 Other
1.4 Global Ixazomib Market Size & Forecast
1.4.1 Global Ixazomib Sales in Value (2016-2026))
1.4.2 Global Ixazomib Sales in Volume (2016-2026)
1.4.3 Global Ixazomib Price by Type (2016-2026) & (USD/Unit)
1.5 Global Ixazomib Production Capacity Analysis
1.5.1 Global Ixazomib Total Production Capacity (2016-2026)
1.5.2 Global Ixazomib Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Ixazomib Market Drivers
1.6.2 Ixazomib Market Restraints
1.6.3 Ixazomib Trends Analysis
2 Manufacturers Profiles
2.1 Takeda
2.1.1 Takeda Details
2.1.2 Takeda Major Business
2.1.3 Takeda Ixazomib Product and Services
2.1.4 Takeda Ixazomib Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Ixazomib Sales by Manufacturer
3.1 Global Ixazomib Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Ixazomib Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Ixazomib
3.4 Market Concentration Rate
3.4.1 Top 3 Ixazomib Manufacturer Market Share
3.4.2 Top 6 Ixazomib Manufacturer Market Share
3.5 Global Ixazomib Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Ixazomib Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Ixazomib Market Size by Region
4.1.1 Global Ixazomib Sales in Volume by Region (2016-2026)
4.1.2 Global Ixazomib Revenue by Region (2016-2026)
4.2 North America Ixazomib Revenue (2016-2026)
4.3 Europe Ixazomib Revenue (2016-2026)
4.4 Asia-Pacific Ixazomib Revenue (2016-2026)
4.5 South America Ixazomib Revenue (2016-2026)
4.6 Middle East and Africa Ixazomib Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Ixazomib Sales in Volume by Type (2016-2026)
5.2 Global Ixazomib Revenue by Type (2016-2026)
5.3 Global Ixazomib Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Ixazomib Sales in Volume by Application (2016-2026)
6.2 Global Ixazomib Revenue by Application (2016-2026)
6.3 Global Ixazomib Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Ixazomib Sales by Type (2016-2026)
7.2 North America Ixazomib Sales by Application (2016-2026)
7.3 North America Ixazomib Market Size by Country
7.3.1 North America Ixazomib Sales in Volume by Country (2016-2026)
7.3.2 North America Ixazomib Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Ixazomib Sales by Type (2016-2026)
8.2 Europe Ixazomib Sales by Application (2016-2026)
8.3 Europe Ixazomib Market Size by Country
8.3.1 Europe Ixazomib Sales in Volume by Country (2016-2026)
8.3.2 Europe Ixazomib Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Ixazomib Sales by Type (2016-2026)
9.2 Asia-Pacific Ixazomib Sales by Application (2016-2026)
9.3 Asia-Pacific Ixazomib Market Size by Region
9.3.1 Asia-Pacific Ixazomib Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Ixazomib Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Ixazomib Sales by Type (2016-2026)
10.2 South America Ixazomib Sales by Application (2016-2026)
10.3 South America Ixazomib Market Size by Country
10.3.1 South America Ixazomib Sales in Volume by Country (2016-2026)
10.3.2 South America Ixazomib Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Ixazomib Sales by Type (2016-2026)
11.2 Middle East & Africa Ixazomib Sales by Application (2016-2026)
11.3 Middle East & Africa Ixazomib Market Size by Country
11.3.1 Middle East & Africa Ixazomib Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Ixazomib Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Ixazomib Typical Distributors
12.3 Ixazomib Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Ixazomib Revenue by Type, (USD Million), 2021-2026
Table 2. Global Ixazomib Revenue by Application, (USD Million), 2021-2026
Table 3. Takeda Basic Information, Manufacturing Base and Competitors
Table 4. Takeda Major Business
Table 5. Takeda Ixazomib Product and Services
Table 6. Takeda Ixazomib Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Global Ixazomib Sales by Manufacturer (2019-2021e) & (K Units)
Table 8. Global Ixazomib Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 9. Market Position of Manufacturers in Ixazomib, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 10. Global Ixazomib Production Capacity by Company, (K Units): 2020 VS 2021
Table 11. Head Office and Ixazomib Production Site of Key Manufacturer
Table 12. Global Ixazomib Sales by Region (2016-2021e) & (K Units)
Table 13. Global Ixazomib Sales by Region (2021-2026) & (K Units)
Table 14. Global Ixazomib Revenue by Region (2016-2021e) & (USD Million)
Table 15. Global Ixazomib Revenue by Region (2021-2026) & (USD Million)
Table 16. Global Ixazomib Sales by Type (2016-2021e) & (K Units)
Table 17. Global Ixazomib Sales by Type (2021-2026) & (K Units)
Table 18. Global Ixazomib Revenue by Type (2016-2021e) & (USD Million)
Table 19. Global Ixazomib Revenue by Type (2021-2026) & (USD Million)
Table 20. Global Ixazomib Price by Type (2016-2021e) & (USD/Unit)
Table 21. Global Ixazomib Price by Type (2021-2026) & (USD/Unit)
Table 22. Global Ixazomib Sales by Application (2016-2021e) & (K Units)
Table 23. Global Ixazomib Sales by Application (2021-2026) & (K Units)
Table 24. Global Ixazomib Revenue by Application (2016-2021e) & (USD Million)
Table 25. Global Ixazomib Revenue by Application (2021-2026) & (USD Million)
Table 26. Global Ixazomib Price by Application (2016-2021e) & (USD/Unit)
Table 27. Global Ixazomib Price by Application (2021-2026) & (USD/Unit)
Table 28. North America Ixazomib Sales by Country (2016-2021e) & (K Units)
Table 29. North America Ixazomib Sales by Country (2021-2026) & (K Units)
Table 30. North America Ixazomib Revenue by Country (2016-2021e) & (USD Million)
Table 31. North America Ixazomib Revenue by Country (2021-2026) & (USD Million)
Table 32. North America Ixazomib Sales by Type (2016-2021e) & (K Units)
Table 33. North America Ixazomib Sales by Type (2021-2026) & (K Units)
Table 34. North America Ixazomib Sales by Application (2016-2021e) & (K Units)
Table 35. North America Ixazomib Sales by Application (2021-2026) & (K Units)
Table 36. Europe Ixazomib Sales by Country (2016-2021e) & (K Units)
Table 37. Europe Ixazomib Sales by Country (2021-2026) & (K Units)
Table 38. Europe Ixazomib Revenue by Country (2016-2021e) & (USD Million)
Table 39. Europe Ixazomib Revenue by Country (2021-2026) & (USD Million)
Table 40. Europe Ixazomib Sales by Type (2016-2021e) & (K Units)
Table 41. Europe Ixazomib Sales by Type (2021-2026) & (K Units)
Table 42. Europe Ixazomib Sales by Application (2016-2021e) & (K Units)
Table 43. Europe Ixazomib Sales by Application (2021-2026) & (K Units)
Table 44. Asia-Pacific Ixazomib Sales by Region (2016-2021e) & (K Units)
Table 45. Asia-Pacific Ixazomib Sales by Region (2021-2026) & (K Units)
Table 46. Asia-Pacific Ixazomib Revenue by Region (2016-2021e) & (USD Million)
Table 47. Asia-Pacific Ixazomib Revenue by Region (2021-2026) & (USD Million)
Table 48. Asia-Pacific Ixazomib Sales by Type (2016-2021e) & (K Units)
Table 49. Asia-Pacific Ixazomib Sales by Type (2021-2026) & (K Units)
Table 50. Asia-Pacific Ixazomib Sales by Application (2016-2021e) & (K Units)
Table 51. Asia-Pacific Ixazomib Sales by Application (2021-2026) & (K Units)
Table 52. South America Ixazomib Sales by Country (2016-2021e) & (K Units)
Table 53. South America Ixazomib Sales by Country (2021-2026) & (K Units)
Table 54. South America Ixazomib Revenue by Country (2016-2021e) & (USD Million)
Table 55. South America Ixazomib Revenue by Country (2021-2026) & (USD Million)
Table 56. South America Ixazomib Sales by Type (2016-2021e) & (K Units)
Table 57. South America Ixazomib Sales by Type (2021-2026) & (K Units)
Table 58. South America Ixazomib Sales by Application (2016-2021e) & (K Units)
Table 59. South America Ixazomib Sales by Application (2021-2026) & (K Units)
Table 60. Middle East & Africa Ixazomib Sales by Country (2016-2021e) & (K Units)
Table 61. Middle East & Africa Ixazomib Sales by Country (2021-2026) & (K Units)
Table 62. Middle East & Africa Ixazomib Revenue by Country (2016-2021e) & (USD Million)
Table 63. Middle East & Africa Ixazomib Revenue by Country (2021-2026) & (USD Million)
Table 64. Middle East & Africa Ixazomib Sales by Type (2016-2021e) & (K Units)
Table 65. Middle East & Africa Ixazomib Sales by Type (2021-2026) & (K Units)
Table 66. Middle East & Africa Ixazomib Sales by Application (2016-2021e) & (K Units)
Table 67. Middle East & Africa Ixazomib Sales by Application (2021-2026) & (K Units)
Table 68. Direct Channel Pros & Cons
Table 69. Indirect Channel Pros & Cons
Table 70. Ixazomib Typical Distributors
Table 71. Ixazomib Typical Customers
List of Figures
Figure 1. Ixazomib Picture
Figure 2. Global Ixazomib Sales Market Share by Type in 2020
Figure 3. 2.3mg Capsules
Figure 4. 3mg Capsules
Figure 5. 4mg Capsules
Figure 6. Global Ixazomib Sales Market Share by Application in 2020
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Drug Center
Figure 10. Other
Figure 11. Global Ixazomib Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 12. Global Ixazomib Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. United States Ixazomib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Canada Ixazomib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Mexico Ixazomib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Germany Ixazomib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. France Ixazomib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. United Kingdom Ixazomib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Russia Ixazomib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Italy Ixazomib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. China Ixazomib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Japan Ixazomib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Korea Ixazomib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. India Ixazomib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Southeast Asia Ixazomib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Australia Ixazomib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Brazil Ixazomib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Egypt Ixazomib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Saudi Arabia Ixazomib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. South Africa Ixazomib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Turkey Ixazomib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Global Ixazomib Sales (2016-2026) & (K Units)
Figure 33. Global Ixazomib Production Capacity (2016-2026) & (K Units)
Figure 34. Global Ixazomib Production Capacity by Geographic Region: 2020 VS 2021
Figure 35. Ixazomib Market Drivers
Figure 36. Ixazomib Market Restraints
Figure 37. Ixazomib Market Trends
Figure 38. Global Ixazomib Sales Market Share by Manufacturer in 2020
Figure 39. Global Ixazomib Revenue Market Share by Manufacturer in 2020
Figure 40. Ixazomib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 41. Top 3 Ixazomib Manufacturer (Revenue) Market Share in 2020
Figure 42. Top 6 Ixazomib Manufacturer (Revenue) Market Share in 2020
Figure 43. Global Ixazomib Sales Market Share by Region (2016-2026)
Figure 44. Global Ixazomib Revenue Market Share by Region (2016-2026)
Figure 45. North America Ixazomib Revenue (2016-2026) & (USD Million)
Figure 46. Europe Ixazomib Revenue (2016-2026) & (USD Million)
Figure 47. Asia-Pacific Ixazomib Revenue (2016-2026) & (USD Million)
Figure 48. South America Ixazomib Revenue (2016-2026) & (USD Million)
Figure 49. Middle East & Africa Ixazomib Revenue (2016-2026) & (USD Million)
Figure 50. Global Ixazomib Sales Market Share by Type (2016-2026)
Figure 51. Global Ixazomib Revenue Market Share by Type (2016-2026)
Figure 52. Global Ixazomib Price by Type (2016-2026) & (USD/Unit)
Figure 53. Global Ixazomib Sales Market Share by Application (2016-2026)
Figure 54. Global Ixazomib Revenue Market Share by Application (2016-2026)
Figure 55. Global Ixazomib Price by Application (2016-2026) & (USD/Unit)
Figure 56. North America Ixazomib Sales Market Share by Country (2016-2026)
Figure 57. North America Ixazomib Revenue Market Share by Country (2016-2026)
Figure 58. North America Ixazomib Sales Market Share by Type (2016-2026)
Figure 59. North America Ixazomib Sales Market Share by Application (2016-2026)
Figure 60. Europe Ixazomib Sales Market Share by Country (2016-2026)
Figure 61. Europe Ixazomib Revenue Market Share by Country (2016-2026)
Figure 62. Europe Ixazomib Sales Market Share by Type (2016-2026)
Figure 63. Europe Ixazomib Sales Market Share by Application (2016-2026)
Figure 64. Asia-Pacific Ixazomib Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Ixazomib Revenue Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Ixazomib Sales Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Ixazomib Sales Market Share by Application (2016-2026)
Figure 68. South America Ixazomib Sales Market Share by Country (2016-2026)
Figure 69. South America Ixazomib Revenue Market Share by Country (2016-2026)
Figure 70. South America Ixazomib Sales Market Share by Type (2016-2026)
Figure 71. South America Ixazomib Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Ixazomib Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Ixazomib Revenue Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Ixazomib Sales Market Share by Type (2016-2026)
Figure 75. Middle East & Africa Ixazomib Sales Market Share by Application (2016-2026)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source
世界のデンプン空カプセル市場 2021：企業別、地域別、種類・用途別 The Starch Empty Capsules market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…- 世界の吸入カプセル市場 2021：企業別、地域別、種類・用途別 The Inhalation Capsules market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…
- 世界の茶カプセル市場 2021：企業別、地域別、種類・用途別 The Tea Capsules market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recen…
- 世界のオイルソフトジェルカプセル市場 2021：企業別、地域別、種類・用途別 The Oil Softgel Capsules market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulation…
- 世界の洗剤カプセル市場 2021：企業別、地域別、種類・用途別 The Detergent Capsules market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations,…